<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149620">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01152515</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 4-2010-0022</org_study_id>
    <nct_id>NCT01152515</nct_id>
  </id_info>
  <brief_title>A Low Dose Remifentanil Infusion During Tracheal Extubation in Surgical Intensive Care Unit Patients</brief_title>
  <official_title>A Low Dose Remifentanil Infusion During Tracheal Extubation in Surgical Intensive Care Unit Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <brief_summary>
    <textblock>
      Tracheal extubation can be associated with hyperdynamic circulatory response. The
      investigators examined the effect of maintaining a remifentanil infusion on the
      cardiovascular response during extubation in propofol-remifentanil sedated patients after
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular response during extubation</measure>
    <time_frame>10 min</time_frame>
    <description>Heart rate and mean arterial pressure at extubation and 5, 10 min from extubation
Coughing grade at extubation (0 = no coughing, 1 = a single cough, 2 = more than one episode of non-sustained coughing, 3 = sustained and repetitive coughing with head lift)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of awake and extubation</measure>
    <time_frame>1 hour</time_frame>
    <description>Time of BIS &gt; 80 : time between 'stopping of propofol' and Time of extubation : time between 'stopping of propofol' and 'extubation'</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tracheal Extubation</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>stopping of propofol and remifentanil infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remifentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>stopping of propofol and maintenance of remifentanil infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>Control group : stopping of propofol and remifentanil infusion Remifentanil group : stopping of propofol and maintenance of remifentanil infusion</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Remifentanil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age â‰¥ 20

          2. Short term ventilator care after surgery in intensive care unit

        Exclusion Criteria:

          1. pneumonia

          2. chronic obstructive lung disease

          3. asthma

          4. end stage renal disease

          5. risk factors for aspiration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <lastchanged_date>March 10, 2011</lastchanged_date>
  <firstreceived_date>June 28, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute</name_title>
    <organization>Yonsei University College of Medicine</organization>
  </responsible_party>
  <keyword>safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
